Back to Search
LYLE BERRY, M.D.
M.D.
Hospitalist Physician
NPI: 1871730036IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
7471625-1205(UT)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
7471625-1205(UT)
CMS Specialties
PrimaryHOSPITALIST
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 2008
Research & Publications (20)
Quantification of viable tumor microvascular characteristics by multispectral analysis.
PMID 18421695·Magn Reson Med·2008
7-preclinical
Potent oncolytic activity of human enteroviruses against human prostate cancer.
PMID 18288643·Prostate·2008
7-preclinical
Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
PMID 14742549·Infect Immun·2004
7-preclinical
Reproductive success of rose-ringed parakeets Psittacula krameri in a captive UK population.
PMID 19623541·Pest Manag Sci·2009
7-preclinical
Esterase activities in the blood, liver and intestine of several preclinical species and humans.
PMID 19601867·Drug Metab Lett·2009
4-observational
Intravascular targeting of a new anticoagulant heparin compound.
PMID 19519374·Cardiovasc Hematol Disord Drug Targets·2009
6-review
In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
PMID 19567590·Clin Cancer Res·2009
7-preclinical
Impact of supplemental oxygen in mechanically ventilated adult and infant mice.
PMID 18992373·Respir Physiol Neurobiol·2009
7-preclinical
Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung.
PMID 19112103·Am J Physiol Lung Cell Mol Physiol·2009
7-preclinical
Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.
PMID 19276360·Cancer Res·2009
7-preclinical
Leonard L. Berry, PhD: The Mayo culture of leadership.
PMID 19161027·Healthc Financ Manage·2009
8-other
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
PMID 19572069·Thromb Haemost·2009
4-observational
In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
PMID 19041426·Int Immunopharmacol·2009
7-preclinical
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.
PMID 19010992·Eur Respir J·2009
8-other
Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model.
PMID 19652880·Thromb Haemost·2009
4-observational
Healthy start program and feto-infant morbidity outcomes: evaluation of program effectiveness.
PMID 18690524·Matern Child Health J·2009
8-other
Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer.
PMID 19671761·Mol Cancer Ther·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8TH AVE. & C ST., LDS/IMC HOSPITALIST GROUP
SALT LAKE CITY, UT 84143 - Phone
- (801) 408-5482
Quick Facts
- NPI
- 1871730036
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile